A new randomized clinical trial has revealed that just 24 minutes of listening to specially designed music paired with ...
The development of robust clinical trial methodologies increasingly relies on advanced statistical frameworks for model selection and the characterisation of dose–response relationships. With modern ...
Hepatic steatosis is a core pathological feature of metabolic dysfunction-associated steatotic liver disease (MASLD). It not ...
Although the correlate of protection is unknown, the findings show that standard doses should be used in infants.
CytoAgents Inc. completed the dose-limiting toxicity observation for the first cohort in a trial targeting CRS in blood cancer patients. The Safety Review Committee approved dose escalation for the ...
Phase 1b trial shows 40% response rate for onvansertib plus paclitaxel in metastatic triple-negative breast cancer, with manageable toxicity. Cardiff Oncology, Inc. announced promising results from a ...
Please provide your email address to receive an email when new articles are posted on . Patients with ankylosing spondylitis who had an inadequate response to secukinumab at 16 weeks saw no benefit at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results